Cigna And Humana Re-Engage In Merger Talks

Cigna Group has reinitiated discussions with Humana regarding a potential merger, following the collapse of their discussions last year.

According to a Bloomberg News report, which cited sources privy to the development, the talks are in the preliminary stages and no decisions have been made.

In December last year, Cigna abandoned its plans to merge with Humana due to disagreements over financial terms.

A merger of the US health insurance giants would create an industry leader valued at nearly $140bn.

The latest discussions come as the federal government pressures Humana to control Medicare costs, impacting its finances and market value. An agreement would likely be among the top five health insurance deals, according to Bloomberg data.

Cigna plans to finalise the sale of its Medicare Advantage business soon, which could ease antitrust concerns in a potential deal with Humana by eliminating overlapping services.

Cigna, known for its employer-sponsored healthcare plans, is in the process of divesting its Medicare Advantage business, having agreed to a $3.3bn deal with Health Care Service earlier this year.

On the other hand, Humana has faced a challenging year, with its value dropping nearly 40% due to various factors including declining enrolments in its Medicare plans and increased medical costs.

For the year ending 31 December 2023, Cigna reported a net income of $5.16bn, a 22% decline from $6.7bn in the previous year.

“Cigna and Humana re-engage in merger talks” was originally created and published by Life Insurance International, a GlobalData owned brand.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square